EP3554511
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.12.2017:
10.7.2024:
17880962.0
:
14.12.2037
:
COMBINATION OF AN IMMUNE CHECKPOINT INHIBITOR PD-1 OR PD-L1 INHIBITOR WITH AN HEPARAN SULFATE MIMETIC AND THE USE THEREOF IN THE TREATMENT OR PREVENTION OF CANCER
15.12.2017
10.7.2024
:
Progen PG500 Series Pty Ltd:
184 Moorabool Street, Geelong, Victoria 3220, AU
:
DREDGE, Keith:
Geelong, Victoria 3220, AU
:
2016905199:
15.12.2016:
AU
:
AU2017051402:
15.12.2017
:
A61K 31/704, A61K 31/702, A61K 31/573, A61K 39/395, A61P 35/00